Frederic Grabowski: Difference between revisions

Revision as of 09:26, 24 September 2021

B.Sc., Ph.D. student

Contact

e-mail at ippt.pan.pl: fgrabows
tel.: +48 22 8261280 ext. 450
room: 310

Institute of Fundamental Technological Research
Polish Academy of Sciences
Pawińskiego 5B, 02-106 Warsaw, Poland

Publications

SARS-CoV-2 Variant of Concern 202012/01 has about twofold replicative advantage and acquires concerning mutations
Grabowski F, Preibisch G, Giziński S, Kochańczyk M, Lipniacki T
Viruses 13(3):392 (2021)
CrossRef medRxiv | PDF SuppInfo-ZIP Correspondence

Super-spreading events initiated the exponential growth phase of COVID-19 with R₀ higher than initially estimated
Kochańczyk M, Grabowski F, Lipniacki T
Royal Society Open Science 7:200786 (2020)
CrossRef | PDF SuppInfo-PDF Correspondence

Dynamics of COVID-19 pandemic at constant and time-dependent contact rates
Kochańczyk M, Grabowski F, Lipniacki T
Mathematical Modelling of Natural Phenomena 15:28 (2020)
CrossRef | PDF SuppCode

Asymptotic safety and conformal standard model
Grabowski F, Kwapisz JH, Meissner KA
Physical Review D 99(11):115029 (2019)
CrossRef arXiv

Limits to the rate of information transmission through the MAPK pathway
Grabowski F, Czyż P, Kochańczyk M, Lipniacki T
Journal of the Royal Society Interface 16(152):20180792 (2019)
PubMed CrossRef | PDF SuppCode

@@ Line 13: / Line 13: @@
 ===Publications===
-* '''SARS-CoV-2 Variant of Concern 202012/01 has about twofold replicative advantage and&nbsp;acquires concerning mutations'''<br/><span class="author">Grabowski&nbsp;F</span>, <span class="author">Preibisch&nbsp;G</span>, <span class="author">Giziński&nbsp;S</span>, <span class="author">Kochańczyk&nbsp;M</span>, <span class="author">Lipniacki&nbsp;T</span><br/>''Viruses'' <u>13</u>(3):392 (2021)<br/>[https://doi.org/10.3390/v13030392 CrossRef] [https://doi.org/10.1101/2020.12.28.20248906 medRxiv] | [https://www.mdpi.com/1999-4915/13/3/392/pdf PDF] [https://www.mdpi.com/1999-4915/13/3/392/s1 Supplement-ZIP] [https://www.mdpi.com/1999-4915/13/3/392/review_report Correspondence]
+* '''SARS-CoV-2 Variant of Concern 202012/01 has about twofold replicative advantage and&nbsp;acquires concerning mutations'''<br/><span class="author">Grabowski&nbsp;F</span>, <span class="author">Preibisch&nbsp;G</span>, <span class="author">Giziński&nbsp;S</span>, <span class="author">Kochańczyk&nbsp;M</span>, <span class="author">Lipniacki&nbsp;T</span><br/>''Viruses'' <u>13</u>(3):392 (2021)<br/>[https://doi.org/10.3390/v13030392 CrossRef] [https://doi.org/10.1101/2020.12.28.20248906 medRxiv] | [https://www.mdpi.com/1999-4915/13/3/392/pdf PDF] [https://www.mdpi.com/1999-4915/13/3/392/s1 SuppInfo-ZIP] [https://www.mdpi.com/1999-4915/13/3/392/review_report Correspondence]
 * '''Super-spreading events initiated the exponential growth phase of COVID-19 with <i>R</i><sub>0</sub> higher&nbsp;than initially estimated'''<br/><span class="author">Kochańczyk M</span>, <span class="author">Grabowski F</span>, <span class="author">Lipniacki T</span><br/>''Royal Society Open Science'' <u>7</u>:200786 (2020)<br/> [https://doi.org/10.1098/rsos.200786 CrossRef] | [https://royalsocietypublishing.org/doi/pdf/10.1098/rsos.200786 PDF] [https://royalsocietypublishing.org/doi/suppl/10.1098/rsos.200786 SuppInfo-PDF] [https://royalsocietypublishing.org/action/downloadSupplement?doi=10.1098/rsos.200786&file=rsos200786_review_history.pdf Correspondence]